About#
Note
dcmri is under construction. At this stage, the API may still change and features may be deprecated without warning.
Funding#
Development of dcmri was funded by the European Union’s Innovative
Health Initiative as part of the
TRISTAN project
TRISTAN is a public-private partnership aiming to validate imaging biomarkers
for drug safety assessment. TRISTAN applies DCMRI methods to assess
liver-mediated drug-drug interactions (DDI) and drug-induced toxicity in liver
(DILI) and lung (DIILD). A
DCMRI biomarker for DDI based
on an implementation in dcmri has been accepted by the US food and drug
administration (FDA) in their formal
biomarker qualification program.
See the website of the TRISTAN project for more information.
Maintainers#
dcmri is maintained by the
medical imaging group
at the University of Sheffield, UK.
Contributors:
